Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain HOLX message board posts where the ticker symbol HOLX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest HOLX SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, item 8.01
Acc-no: 0001193125-18-047254 (34 Act)  Size: 13 KB
2018-02-15 001-36214
18617881
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-006075 Size: 4 KB
2018-02-14
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000080255-18-002301 (34 Act)  Size: 6 KB
2018-02-14 005-41074
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001422848-18-000320 (34 Act)  Size: 8 KB
2018-02-14 005-41074
18605807
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001422849-18-000055 (34 Act)  Size: 8 KB
2018-02-14 005-41074
18605196
SC TO-I/A  Documents [Amend] Tender offer statement by Issuer
Acc-no: 0001193125-18-038004 (34 Act)  Size: 36 KB
2018-02-09 005-41074
18591990
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000932471-18-004072 (34 Act)  Size: 45 KB
2018-02-09 005-41074
18590421
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0000859737-18-000002 (34 Act)  Size: 8 MB
2018-02-08 001-36214
18586061
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001144204-18-006616 (34 Act)  Size: 699 KB
2018-02-08 001-36214
18585713
SC 13G  Documents Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000902219-18-000311 (34 Act)  Size: 38 KB
2018-02-08 005-41074
18584157
More HOLX SEC Filings


Related news from
Thu, 22 Feb 2018
13:07:00 +0000
Hologic Signs Exclusive Agreement with DEXALYTICS™ to Offer Groundbreaking Body Composition Analysis Software for Athletes
MARLBOROUGH, Mass., Feb. 22, 2018 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today it has signed an agreement with the University of Minnesota to be the exclusive provider of Dexalytics: TEAMS™ in North America. The partnership provides the sports science and human performance industry with the first solution to harness body composition data obtained from dual X-ray absorptiometry (DXA) scans, compare it to sport- and position-specific standards, and provide actionable information that can help collegiate and professional trainers, coaches and medical staff train better athletes.
Tue, 20 Feb 2018
12:50:00 +0000
Report: Developing Opportunities within NewJersey Resources, Masimo, New Mountain Finance, Hess, Hologic, and UnitedHealth Group — Future Expectations, Projections Moving into 2018
NEW YORK, Feb. 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NewJersey ...
Fri, 16 Feb 2018
14:37:02 +0000
Hologic Banks on Diagnostics, GYN Surgical Prospects Bright
Hologic (HOLX) stays upbeat about GYN Surgical on the recent commercial launch of MyoSure MANUAL device in the United States.
Fri, 16 Feb 2018
13:08:06 +0000
See what the IHS Markit Score report has to say about Hologic Inc.
Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 14. Index (PMI) data, output in the Healthcare sector is rising.
Mon, 12 Feb 2018
17:54:22 +0000
Kahn Brothers Sells New York Times, Citigroup, Hologic
Largest sales of the 4th quarter
Mon, 12 Feb 2018
13:15:00 +0000
Hologic to Webcast Presentations at Upcoming Investor Conferences
MARLBOROUGH, Mass. , Feb. 12, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The LEERINK Partners 7 th Annual Global ...
Fri, 09 Feb 2018
14:51:02 +0000
Hologic (HOLX) Q1 Earnings & Revenues Top, Margins Down
Solid growth at Hologic's (HOLX) Molecular Diagnostics, Breast Health and international business drives the top line in Q1.
Thu, 08 Feb 2018
21:09:15 +0000
Hologic beats Street 1Q forecasts
On a per-share basis, the Marlborough, Massachusetts-based company said it had net income of $1.45. Earnings, adjusted for non-recurring gains, were 55 cents per share. The results exceeded Wall Street ...
Thu, 08 Feb 2018
21:01:00 +0000
Hologic Announces Financial Results for First Quarter of Fiscal 2018
-- Revenue of $791.1 Million Grows 7.7%, 6.7% in Constant Currency -- -- Company Posts GAAP Diluted EPS of $1.45 , Non-GAAP Diluted EPS of $0.55 -- -- Company Reiterates Full-Year Revenue Guidance, Raises ...
Thu, 08 Feb 2018
17:20:00 +0000
Hologic, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Hologic, Inc. (NASDAQ: HOLX ) will be discussing their earnings results in their Q1 Earnings Call to be held on February 8, 2018 at 4:30 PM Eastern Time. ...
Wed, 07 Feb 2018
15:20:03 +0000
CAH vs. HOLX: Which Will Fare Better This Earnings Season?
Here we look at the major factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.
Tue, 06 Feb 2018
13:52:01 +0000
Should You Sell Hologic (HOLX) Before Earnings?
Hologic (HOLX) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Mon, 29 Jan 2018
21:02:00 +0000
Hologic Announces Upcoming Put Option and Notice of Redemption of 2.00% Convertible Senior Notes Due 2042
MARLBOROUGH, Mass., Jan. 29, 2018 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that holders of the 2.00% Convertible Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012 have the right to surrender their notes for repurchase by the Company.  This right is pursuant to the put option under the base indenture governing the notes dated December 10, 2007, as supplemented by the third supplemental indenture dated March 5, 2012 (collectively, the indenture). The put option entitles each holder of the notes to require the Company to repurchase in cash all or part (in principal amounts equal to $1,000 or multiples thereof) of the notes on March 1, 2018 (the put option repurchase date) at a price equal to 100% of the accreted principal amount of the notes, plus accrued and unpaid interest, if any, upon the terms and subject to the conditions set forth in the indenture and the notes.
Mon, 29 Jan 2018
15:59:03 +0000
Can Molecular Diagnostics Arm Up Hologic (HOLX) Q1 Earnings?
Molecular Diagnostics unit's stellar performance in the first quarter of 2018 is likely to drive Hologic (HOLX) in Q1.
Thu, 25 Jan 2018
13:17:00 +0000
Aptima® HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
MARLBOROUGH, Mass., Jan. 25, 2018 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that the United States Food and Drug Administration (FDA) has granted PMA approval for the Aptima® HBV Quant Assay for quantitation of hepatitis B viral load on the fully automated Panther® system. The Aptima HBV Quant assay represents the newest addition to the Panther system's viral load menu, joining the previously approved Aptima HIV-1 Quant Assay (for human immunodeficiency virus) and Aptima HCV Quant Dx Assay (for hepatitis C virus).  All three new assays use Hologic's proprietary real-time transcription-mediated amplification (TMA), which provides highly sensitive and specific performance.
Mon, 22 Jan 2018
14:05:00 +0000
Hologic's Cynosure Division Launches TempSure™ Envi
MARLBOROUGH, Mass., Jan. 22, 2018 /PRNewswire/ -- Hologic's (HOLX) Cynosure division announced today the launch of TempSure™ Envi – an FDA-cleared advanced radiofrequency device that minimizes facial fine lines and wrinkles, tightens skin through soft tissue coagulation, and improves the appearance of cellulite. TempSure™ Envi is a simpler way for patients to maintain beautiful skin. Unlike other radiofrequency devices, TempSure™ Envi has the distinct advantage of Therapeutic Logic Control (TLC) – a system that links treatment time with target temperature, allowing for consistent treatment temperatures and high patient comfort levels.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "It [ValueForum] has provided me with eye opening information on a wide scale. The collective wisdom of the membership is astounding and somewhat intimidating; but useful input is appreciated pretty universally." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards